Stockscreener 앱 받기
11.21
1.95%
0.2147
전일 마감가:
$11.00
열려 있는:
$11.8
하루 거래량:
3,236
Relative Volume:
1.63
시가총액:
$102.04M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.50%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$11.21
$11.80
1주일 범위
$10.82
$11.80
52주 변동 폭
$10.00
$11.80
Research Alliance Corp Iv Stock (RACD) Company Profile
Compare RACD vs LION, XXI, UMAC, CCXI, BCSS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RACD
Research Alliance Corp Iv
|
11.21 | 98.36M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
12.98 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.54 | 1.57B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
25.73 | 984.55M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
15.93 | 764.20M | 0 | 0 | 0 | 0.0647 |
BCSS
Bain Capital Gss Investment Corp
|
10.21 | 597.48M | 0 | 8.29M | -686.50K | 0.142 |
Research Alliance Corp Iv 주식(RACD)의 최신 뉴스
OHB Pediatrics Ltd. entered into a definitive business combination agreement to acquire Research Alliance Corporation III from Research Alliance Holdings III LLC and others for approximately $160 million in a reverse merger transaction. - marketscreener.com
Form 4 Research Alliance Corporation III For: 27 July By Investing.com - Investing.com Nigeria
Research Alliance to Acquire OHB Pediatrics in Stock Deal Valued at $160 Million Plus SAFEs - TradingView
Oak Hill Bio, Research Alliance III (RACC) plan SPAC merger - Stock Titan
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome - Yahoo Finance
Research Alliance Corporation IV Revenue Breakdown – NASDAQ:RACD - TradingView
PERCEPTIVE ADVISORS LLC Acquires 700,000 Shares in Research Alli - GuruFocus
Meridia RE IV Socimi announces EUR 0.01 per share dividend for 2025 results - Bitget
COMMODORE CAPITAL LP Acquires 500,000 Shares in Research Alliance Corp IV - GuruFocus
RACD Price History for Research Alliance Corporation IV Cl A Stock - Barchart.com
RACD: Research Alliance Corporation IVFull Company Report - Zacks Investment Research
Research Alliance Holdings IV LLC Discloses Investment in Research Alliance Corporation IV with 17% Stake - TradingView
Research Alliance Corporation IV (RACD) sponsor reports 17% ownership - Stock Titan
Research Alliance Corp IV (RACD) investor group reports 5.5% ownership of Class A shares - Stock Titan
Biotechnology Value Fund (RACD) group reveals 6.4% Research Alliance stake - Stock Titan
Research Alliance Corporation IV Completes Initial Public Offering - TipRanks
Research Alliance IV prices IPO for $75M, deposits $75M trust; sponsor buys $2.75M private placement - TradingView
Commodore Capital takes 5.5% position in Research Alliance Corp IV (RACD) - Stock Titan
RACD Stock Latest News - TipRanks
Perceptive Advisors reports 7.7% RACD stake in Research Alliance Corporation IV (RACD) - Stock Titan
Frontier tech research, news & data - MLQ.ai
RACD SEC FilingsResearch Alliance Corp IV 10-K, 10-Q, 8-K Forms - Stock Titan
RACD News Today | Why did Research Alliance Corporation IV stock go up today? - MarketBeat
Research Alliance Corporation IV (RACD) Stock Price, News & Analysis - MarketBeat
Research Alliance Corporation IV (RACD) Stock Trends and Sentiment 2026 - MarketBeat
U.S. IPO Weekly Recap: Csquare And Standard Nuclear Both Underwhelm Amid Cautious Market - Seeking Alpha
Research Alliance Corporation IV (RACD) stock historical prices and data - Yahoo Finance Australia
Cash flow from operating activities of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corp IV (RACD) grants 275,000 shares to director entity - Stock Titan
Research Alliance Corp IV (RACD) sponsor gets 275K share grant - Stock Titan
Research Alliance Corporation IV (RACD) seeks $75M SPAC IPO - Stock Titan
Book value per share of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
RACD Price Today: Research Alliance Corporation IV Stock Price, Quote & Chart - mexc.co
Price to sales forward of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) 10K Form and Latest SEC Filings 2026 - MarketBeat
Research Alliance Corporation IV (RACD) Stock Chart and Price History 2026 - MarketBeat
Research Alliance Corporation IV Prices $75 Million IPO, Targets Healthcare Sector on Nasdaq - Minichart
Research Alliance IV Completes $75 Million SPAC IPO, Inks Trust, Underwriting and $2.75 Million Private Deal - TradingView
Research Alliance Corporation IV (RACD) completes $75M IPO and trust funding - Stock Titan
Research Alliance Corp IV SEC Filing (Jul 13, 2026) - Stock Titan
Research Alliance Corp IV (NASDAQ: RACD) files exhibits-only registration update - Stock Titan
Research Alliance Corp IV (RACD) director discloses 30,000 convertible Class B shares - Stock Titan
Research Alliance Corp IV (RACD) CFO files initial ownership statement - Stock Titan
Research Alliance Corp IV (RACD) officer Henry Stusnick files initial Form 3 - Stock Titan
Research Alliance IV prices $75M SPAC IPO - MSN
Research Alliance Corp IV (RACD) holder discloses 1.26M Class B shares - Stock Titan
Research Alliance Corporation IV(NasdaqCM: RACD) added to NASDAQ Composite Index - marketscreener.com
Research Alliance Corporation IV prices $75 million IPO at $10.00 per share - scanx.trade
Research Alliance Corporation IV prices $75M IPO on Nasdaq By Investing.com - Investing.com South Africa
Research Alliance Corporation IV prices $75M IPO on Nasdaq - Investing.com
Research Alliance Corporation IV (RACD) Prices $75M IPO - SPACInsider
Research Alliance Corp Iv (RACD) 재무 분석
Research Alliance Corp Iv (RACD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.29%
0.61%
자본화:
|
볼륨(24시간):